Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Terumo (4543.T)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (¥) Price Target (¥) Rating
2022-03-3018641950.0Neutral
2022-05-2520782100.0Neutral
2022-06-171917-No Rating
2023-06-0121512300.0Neutral
2023-08-1820632250.0Neutral
2023-11-2423922495.0Neutral
2024-02-2729053410.0Buy
2024-05-2126983460.0Buy
2024-08-1426953500.0Buy
2024-11-1430553810.0Buy
2025-02-1927443960.0Buy
2025-04-2527633680.0Buy
2025-05-2026943820.0Buy

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.